Abiopharma

🔍 Spurlock Martha S. (Executive)

Company: Commercial Bancgroup, Inc. (CBK)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 836 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 96,310.50 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: By Unified Shares LLC | shares_owned_after: 1,167,820.50 | Footnotes: F3

Footnotes:

• F1: Represents an award of restricted stock units (collectively, the "RSUs" and each, an "RSU") granted pursuant to the Commercial Bancgroup, Inc. 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest 100% on the date of the issuer's 2027 annual meeting of shareholders.
• F2: 95,005.5 of these shares are jointly owned with the reporting person's spouse.
• F3: The reporting person is a member and manager of Unified Shares LLC ("Unified Shares"). The reporting person disclaims beneficial ownership of the shares of the issuer's common stock held by Unified Shares except to the extent of her pecuniary interest therein, if any.